Savings can be achieved if Ugandan company provides HIV drugs to employees.
D000163:Acquired Immunodeficiency Syndrome; D000349:Africa; D017954:Africa South of the Sahara; D000351:Africa, Eastern; D003362:Cost-Benefit Analysis; D003906:Developing Countries; D004194:Disease; D005069:Evaluation Studies as Topic; D015658:HIV Infections; D004364:Pharmaceutical Preparations; D013812:Therapeutics; D014454:Uganda; D014777:Virus Diseases
D004364:Pharmaceutical Preparations
Acquired Immunodeficiency Syndrome--prevention and control; Africa; Africa South Of The Sahara; Cost Effectiveness; Developing Countries; Diseases; Drugs; Eastern Africa; English Speaking Africa; Evaluation; Evaluation Indexes; Hiv Infections--prevention and control; Quantitative Evaluation; Technical Report; Treatment; Uganda; Viral Diseases